FDA Approves First Twice-Yearly PrEP for Long-Acting HIV Prevention. Anderer S. JAMA 2025 Jul 11. doi: 10.1001/jama.2025.10325.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Anderer S. FDA Approves First Twice-Yearly PrEP for Long-Acting HIV Prevention. JAMA 2025 Jul 11. doi: 10.1001/jama.2025.10325.
PMID: 40643930